Financial insights of KMTS

MyFinsight

For the quarter ending 2025-10-31, KMTS made $22,565K in revenue. -$32,785K in net income. Net profit margin of -145.29%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-10-31	2025-07-31
Revenue	22,565	-
Cost of revenue	11,141	-
Gross profit	11,424	-
Research and development	4,878	-
Selling, general and administrative	38,301	-
Total operating expenses	43,179	-
Loss from operations	-31,755	-
Interest expense	1,901	-
Interest income	1,796	-
Other expense (income)	-891	-
Net loss before provision for income taxes	-32,751	-
Provision for income taxes	34	-
Net loss and comprehensive loss	-32,785	-
Net loss and comprehensive loss attributable to kestra medical technologies, ltd	-32,785	-25,826
Net loss attributable to common shareholders, diluted	-	-25,826
Net loss attributable to common shareholders, basic	-32,785	-

Earnings per share, basic	-0.64	-0.5
Earnings per share, diluted	-0.64	-0.5
Weighted average number of shares outstanding, basic	51,376,278	51,304,599
Weighted average number of shares outstanding, diluted	51,376,278	51,304,599